We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$173M
AUM Growth
-$2.52M
Cap. Flow
-$11.6M
Cap. Flow %
-6.69%
Top 10 Hldgs %
29.84%
Holding
957
New
42
Increased
209
Reduced
176
Closed
412

Sector Composition

Rank Sector Weight
1 Technology 10.22%
2 Healthcare 7.65%
3 Consumer Discretionary 7.54%
4 Financials 6.99%
5 Consumer Staples 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TQQQ icon
26
ProShares UltraPro QQQ
TQQQ
$30.5B
$1.32M 0.76%
36,508
+32,054
+720% +$1.1M
PM icon
27
Philip Morris
PM
$312B
$1.23M 0.71%
10,134
+1,800
+22% +$209K
XLU icon
28
State Street Utilities Select Sector SPDR ETF
XLU
$23.4B
$1.23M 0.71%
30,354
-3,220
-10% -$119K
ROST icon
29
Ross Stores
ROST
$80.5B
$1.17M 0.68%
7,801
+234
+3% +$34.5K
SPYV icon
30
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.5B
$1.15M 0.66%
21,780
-2,314
-10% -$118K
AZO icon
31
AutoZone
AZO
$50.9B
$1.12M 0.64%
354
+10
+3% +$30.7K
XLE icon
32
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
$1.09M 0.63%
24,756
-9,686
-28% -$433K
TMO icon
33
Thermo Fisher Scientific
TMO
$214B
$1.02M 0.59%
1,656
+36
+2% +$21.3K
PSLV icon
34
Sprott Physical Silver Trust
PSLV
$11.7B
$1.01M 0.58%
96,788
+63,311
+189% +$635K
ACGL icon
35
Arch Capital
ACGL
$37.2B
$986K 0.57%
8,812
+34
+0.4% +$3.54K
XLV icon
36
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$970K 0.56%
6,297
+2,440
+63% +$370K
CLOB
37
VanEck AA-BB CLO ETF
CLOB
$176M
$966K 0.56%
+19,255
New +$965K
IWF icon
38
iShares Russell 1000 Growth ETF
IWF
$119B
$950K 0.55%
10,120
-28
-0.3% -$2.54K
RSP icon
39
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
$940K 0.54%
5,244
+2,107
+67% +$360K
AGG icon
40
iShares Core US Aggregate Bond ETF
AGG
$138B
$932K 0.54%
9,207
+144
+2% +$14.4K
LQD icon
41
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
$908K 0.52%
8,040
-41
-0.5% -$4.54K
JPM icon
42
JPMorgan Chase
JPM
$950B
$902K 0.52%
4,278
+226
+6% +$47.6K
PG icon
43
Procter & Gamble
PG
$347B
$896K 0.52%
5,172
+70
+1% +$11.9K
SHV icon
44
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$887K 0.51%
8,019
-1,083
-12% -$120K
ORCL icon
45
Oracle
ORCL
$346B
$860K 0.5%
5,045
+3,183
+171% +$461K
TSLA icon
46
Tesla
TSLA
$1.21T
$839K 0.48%
3,206
+1,277
+66% +$291K
NVR icon
47
NVR
NVR
$17.3B
$814K 0.47%
83
-1
-1% -$8.73K
NVDA icon
48
NVIDIA
NVDA
$4.77T
$795K 0.46%
6,548
+950
+17% +$112K
XIMR icon
49
FT Vest US Equity Buffer & Premium Income ETF March
XIMR
$29.9M
$781K 0.45%
25,032
+148
+0.6% +$4.6K
PIT icon
50
VanEck Commodity Strategy ETF
PIT
$299M
$781K 0.45%
16,266
-14,378
-47% -$689K

Similar funds

Castleview Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Castleview Partners held 957 positions worth $173M, down 1.4% from $176M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Castleview Partners withdrew a net $11.6M in Q3 2024, closing 412 positions and reducing 176 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $1.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Castleview Partners opened a new position in VanEck AA-BB CLO ETF worth $966K.

  • Castleview Partners's largest Q3 2024 buy was VanEck AA-BB CLO ETF: 19,255 shares worth $966K.
  • Castleview Partners added most to Bristol-Myers Squibb in Q3 2024, an estimated $2.05M increase.
  • Castleview Partners's biggest Q3 2024 reduction was Alpha Architect 1-3 Month Box ETF, cutting an estimated $7.39M.
  • Castleview Partners fully exited Invesco QQQ Trust in Q3 2024, selling an estimated $1.28M.
  • Castleview Partners's ten largest holdings make up 30% of its $173M portfolio in Q3 2024.
  • Castleview Partners opened 42 new positions and closed 412 in Q3 2024.
  • Castleview Partners's portfolio value fell 1.4% quarter-over-quarter to $173M.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.